{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Asian", "COVID-19", "Herbal medicine", "Plant bioactive compounds", "Prevention", "Treatment"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34623617", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "07"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1007/s11418-021-01575-1"], "Journal": {"ISSN": "1861-0293", "JournalIssue": {"Volume": "76", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jan"}}, "Title": "Journal of natural medicines", "ISOAbbreviation": "J Nat Med"}, "ArticleTitle": "Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention.", "Pagination": {"StartPage": "20", "EndPage": "37", "MedlinePgn": "20-37"}, "Abstract": {"AbstractText": ["The outbreak of COVID-19 disease has led to a search for effective vaccines or drugs. However, insufficient vaccine supplies to meet global demand and no effective approved prescribed drugs for COVID-19 have led some people to consider the use of alternative or complementary medicines, such as traditional herbal medicine. Medicinal plants have various therapeutic properties that depend on the active compounds they contain. Obviously, herbal medicine has had an essential role in treatment and prevention during COVID-19 outbreak, especially in Asian cultures. Hence, we reviewed the uses of herbal medicine in Asian cultures and described the prominent families and species that are sources of antiviral agents against COVID-19 on the basis of case reports, community surveys, and guidelines available in the literature databases. Antiviral efficacy as determined in laboratory testing was assessed, and several promising active compounds with their molecular targets in cell models against SARS-CoV-2 viral infection will be discussed. Our review findings revealed the highly frequent use of Lamiaceae family members, Zingiber officinale, and Glycyrrhiza spp. as medicinal sources for treatment of COVID-19. In addition, several plant bioactive compounds derived from traditional herbal medicine, including andrographolide, panduratin A, baicalein, digoxin, and digitoxin, have shown potent SARS-CoV-2 antiviral activity as compared with some repurposed FDA-approved drugs. These commonly used plants and promising compounds are recommended for further exploration of their safety and efficacy against COVID-19."], "CopyrightInformation": "\u00a9 2021. The Japanese Society of Pharmacognosy."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Public Health Sciences, Chulalongkorn University, Pathumwan, Bangkok, 10330, Thailand."}], "LastName": "Liana", "ForeName": "Desy", "Initials": "D"}, {"Identifier": ["0000-0001-8731-3875"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Public Health Sciences, Chulalongkorn University, Pathumwan, Bangkok, 10330, Thailand. anuchit.p@chula.ac.th."}], "LastName": "Phanumartwiwath", "ForeName": "Anuchit", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Nat Med", "NlmUniqueID": "101518405", "ISSNLinking": "1340-3443"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "CommentsCorrectionsList": [{"RefSource": "J Nat Med. 2022 Jan;76(1):38. doi: 10.1007/s11418-021-01580-4", "PMID": "34687386"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "Authors declared there is no competing of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang Z, Yang L. Chinese herbal medicine: fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol. 2021;270:113869. doi: 10.1016/j.jep.2021.113869.", "ArticleIdList": ["10.1016/j.jep.2021.113869", "PMC7825841", "33485973"]}, {"Citation": "Illian DN, Siregar ES, Sumaiyah S, Utomo AR, Nuryawan A, Basyuni M. Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: a mini-review of SARS-CoV-2 therapeutic targets. Heliyon. 2021;7(1):e06001. doi: 10.1016/j.heliyon.2021.e06001.", "ArticleIdList": ["10.1016/j.heliyon.2021.e06001", "PMC7833933", "33532640"]}, {"Citation": "Teuwen L-A, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389\u2013391. doi: 10.1038/s41577-020-0343-0.", "ArticleIdList": ["10.1038/s41577-020-0343-0", "PMC7240244", "32439870"]}, {"Citation": "Leung EL-H, Pan H-D, Huang Y-F, Fan X-X, Wang W-Y, He F, Cai J, Zhou H, Liu L. The scientific foundation of Chinese herbal medicine against COVID-19. Engineering. 2020;6(10):1099\u20131107. doi: 10.1016/j.eng.2020.08.009.", "ArticleIdList": ["10.1016/j.eng.2020.08.009", "PMC7833648", "33520331"]}, {"Citation": "Akindele AJ, Agunbiade FO, Sofidiya MO, Awodele O, Sowemimo A, Ade-Ademilua O, Akinleye MO, Ishola IO, Orabueze I. COVID-19 Pandemic: a case for phytomedicines. Nat Prod Commun. 2020;15(8):1\u20139. doi: 10.1177/1934578X20945086.", "ArticleIdList": ["10.1177/1934578X20945086", "PMC7429914", "34191921"]}, {"Citation": "Codagenix I (2019) Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19. https://www.prnewswire.com/news-releases/codagenix-and-serum-institute-of-india-initiate-co-development-of-a-scalable-live-attenuated-vaccine-against-the-2019-novel-coronavirus-covid-19-301004654.html. Accessed 25 July 2021"}, {"Citation": "Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(6):803\u2013812. doi: 10.1016/S1473-3099(20)30987-7.", "ArticleIdList": ["10.1016/S1473-3099(20)30987-7", "PMC7906628", "33548194"]}, {"Citation": "Baraniuk C. What do we know about China\u2019s covid-19 vaccines? BMJ. 2021;373:n912. doi: 10.1136/bmj.n912.", "ArticleIdList": ["10.1136/bmj.n912", "33836994"]}, {"Citation": "Britton A, Slifka KMJ, Edens C, Nanduri SA, Bart SM, Shang N, Harizaj A, Armstrong J, Xu K, Ehrlich HY. Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks\u2014Connecticut, December 2020\u2013February 2021. MMWR Morb Mortal Wkly Rep. 2021;70(11):396\u2013401. doi: 10.15585/mmwr.mm7011e3.", "ArticleIdList": ["10.15585/mmwr.mm7011e3", "PMC7976620", "33735160"]}, {"Citation": "Oliver SE. The advisory committee on immunization practices\u2019 interim recommendation for use of moderna COVID-19 vaccine\u2014United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1653\u20131656. doi: 10.15585/mmwr.mm695152e1.", "ArticleIdList": ["10.15585/mmwr.mm695152e1", "PMC9191904", "33382675"]}, {"Citation": "ClinicalTrials.gov. ChulaCov19 mRNA vaccine in healthy adults. https://clinicaltrials.gov/ct2/show/NCT04566276. Accessed 25 July 2021"}, {"Citation": "Cohen J. What went wrong with CureVac's mRNA vaccine? Accessed 20 July 2021"}, {"Citation": "ClinicalTrials.gov. The safety and immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA). https://clinicaltrials.gov/ct2/show/NCT04742842. Accessed 25 July 2021"}, {"Citation": "ClinicalTrials.gov. Safety, tolerability and immunogenicity of INO-4800 followed by electroporation in healthy volunteers for COVID19. https://clinicaltrials.gov/ct2/show/NCT04447781. Accessed 25 July 2021"}, {"Citation": "Knoll MD, Wonodi C. Oxford\u2013AstraZeneca COVID-19 vaccine efficacy. Lancet Inf Dis. 2021;397(10269):72\u201374. doi: 10.1016/S0140-6736(20)32623-4.", "ArticleIdList": ["10.1016/S0140-6736(20)32623-4", "PMC7832220", "33306990"]}, {"Citation": "Livingston EH, Malani PN, Creech CB. The Johnson & Johnson Vaccine for COVID-19. JAMA. 2021;325(15):1575\u20131575. doi: 10.1001/jama.2021.2927.", "ArticleIdList": ["10.1001/jama.2021.2927", "33646285"]}, {"Citation": "Mahase E. Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant. BMJ. 2021;372:n296. doi: 10.1136/bmj.n296.", "ArticleIdList": ["10.1136/bmj.n296", "33526412"]}, {"Citation": "Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q. A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Cent Sci. 2021;7(4):512\u2013533. doi: 10.1021/acscentsci.1c00120.", "ArticleIdList": ["10.1021/acscentsci.1c00120", "PMC8029445", "34056083"]}, {"Citation": "WHO. Coronavirus disease (COVID-19): vaccines. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey. Accessed 11 July 2021"}, {"Citation": "Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, Wu X, Yan Y, Zhao W, Wu J. COVID-19: vaccine development updates. Front Immunol. 2020;11:3435. doi: 10.3389/fimmu.2020.602256.", "ArticleIdList": ["10.3389/fimmu.2020.602256", "PMC7785583", "33424848"]}, {"Citation": "Cragg GM, Newman DJ. Natural product drug discovery in the next millennium. Pharm Biol. 2001;39(sup1):8\u201317. doi: 10.1076/phbi.39.s1.8.0009.", "ArticleIdList": ["10.1076/phbi.39.s1.8.0009", "21554167"]}, {"Citation": "Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009;14(15):804\u2013811. doi: 10.1016/j.drudis.2009.05.009.", "ArticleIdList": ["10.1016/j.drudis.2009.05.009", "19477288"]}, {"Citation": "Sucher NJ. The application of Chinese medicine to novel drug discovery. Expert Opin Drug Disc. 2013;8(1):21\u201334. doi: 10.1517/17460441.2013.739602.", "ArticleIdList": ["10.1517/17460441.2013.739602", "23170842"]}, {"Citation": "Shahrajabian MH, Sun W, Cheng Q. Traditional herbal medicine for the prevention and treatment of cold and flu in the autumn of 2020, overlapped with COVID-19. Nat Prod Commun. 2020;15(8):1\u201310. doi: 10.1177/1934578X20951431.", "ArticleIdList": ["10.1177/1934578X20951431"]}, {"Citation": "Shahrajabian MH, Sun W, Shen H, Cheng Q. Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak. Acta Agric Scand Soil Plant Sci. 2020;70(5):437\u2013443. doi: 10.1080/09064710.2020.1763448.", "ArticleIdList": ["10.1080/09064710.2020.1763448"]}, {"Citation": "Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, Munyoo B, Tuchinda P, Jearawuttanakul K, Seemakhan S, Charoensutthivarakul S, Wongtrakoongate P, Rangkasenee N. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci Rep. 2020;10(1):1\u201312. doi: 10.1038/s41598-020-77003-3.", "ArticleIdList": ["10.1038/s41598-020-77003-3", "PMC7672115", "33203926"]}, {"Citation": "Shahzad F, Anderson D, Najafzadeh M. The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection. Nutrients. 2020;12(9):2573. doi: 10.3390/nu12092573.", "ArticleIdList": ["10.3390/nu12092573", "PMC7551890", "32854262"]}, {"Citation": "van de Sand L, Bormann M, Alt M, Schipper L, Heilingloh CS, Steinmann E, Todt D, Dittmer U, Elsner C, Witzke O. Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease. Viruses. 2021;13(4):609. doi: 10.3390/v13040609.", "ArticleIdList": ["10.3390/v13040609", "PMC8066091", "33918301"]}, {"Citation": "Chen H, Du Q (2020) Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints. 10.20944/preprints202001.0358.v3"}, {"Citation": "Asai A, Konno M, Ozaki M, Otsuka C, Vecchione A, Arai T, Kitagawa T, Ofusa K, Yabumoto M, Hirotsu T. COVID-19 drug discovery using intensive approaches. Int J Mol Sci. 2020;21(8):2839. doi: 10.3390/ijms21082839.", "ArticleIdList": ["10.3390/ijms21082839", "PMC7215413", "32325767"]}, {"Citation": "Jeong GU, Song H, Yoon GY, Kim D, Kwon Y-C. Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review. Front Microbiol. 2020;11:1723. doi: 10.3389/fmicb.2020.01723.", "ArticleIdList": ["10.3389/fmicb.2020.01723", "PMC7381222", "32765482"]}, {"Citation": "Fernandez-Fernandez B, D\u2019marco L, G\u00f3rriz JL, Jacobs-Cach\u00e1 C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A. Exploring sodium glucose co-transporter-2 (SGLT2) inhibitors for organ protection in COVID-19. J Clin Med. 2020;9(7):2030. doi: 10.3390/jcm9072030.", "ArticleIdList": ["10.3390/jcm9072030", "PMC7409231", "32605278"]}, {"Citation": "Liu X, Raghuvanshi R, Ceylan FD, Bolling BW. Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity. J Agric Food Chem. 2020;68(47):13982\u201313989. doi: 10.1021/acs.jafc.0c05064.", "ArticleIdList": ["10.1021/acs.jafc.0c05064", "33179911"]}, {"Citation": "Kim TY, Jeon S, Jang Y, Gotina L, Won J, Ju YH, Kim S, Jang MW, Won W, Park MG, Pae AN, Han S, Kim S, Lee CJ. Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Exp Mol Med. 2021;53(5):956\u2013972. doi: 10.1038/s12276-021-00624-9.", "ArticleIdList": ["10.1038/s12276-021-00624-9", "PMC8143993", "34035463"]}, {"Citation": "Jang M, Park YI, Cha YE, Park R, Namkoong S, Lee JI, Park J. Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro. Evid Based Complement Altern Med. 2020 doi: 10.1155/2020/5630838.", "ArticleIdList": ["10.1155/2020/5630838", "PMC7499281", "32963564"]}, {"Citation": "Souza KFC, Souza BPTM, de Palmer Paix\u00e3o ICN, Burth P, Silva AR, Gon\u00e7alves-de-Albuquerque CF. Na+/K+-ATPase as a target of cardiac glycosides for the treatment of SARS-CoV-2 infection. Front Pharmacol. 2021;12:624704. doi: 10.3389/fphar.2021.624704.", "ArticleIdList": ["10.3389/fphar.2021.624704", "PMC8085498", "33935717"]}, {"Citation": "Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha J. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 2021;84(4):1261\u20131270. doi: 10.1021/acs.jnatprod.0c01324.", "ArticleIdList": ["10.1021/acs.jnatprod.0c01324", "33844528"]}, {"Citation": "Gupta S, Mishra KP, Ganju L. Broad-spectrum antiviral properties of andrographolide. Arch Virol. 2017;162(3):611\u2013623. doi: 10.1007/s00705-016-3166-3.", "ArticleIdList": ["10.1007/s00705-016-3166-3", "27896563"]}, {"Citation": "Maurya VK, Kumar S, Prasad AK, Bhatt MLB, Saxena SK. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virus Dis. 2020;31(2):179\u2013193. doi: 10.1007/s13337-020-00598-8.", "ArticleIdList": ["10.1007/s13337-020-00598-8", "PMC7245990", "32656311"]}, {"Citation": "Shi T-H, Huang Y-L, Chen C-C, Pi W-C, Hsu Y-L, Lo L-C, Chen W-Y, Fu S-L, Lin C-H. Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage. Biochem Biophys Res Commun. 2020;533(3):467\u2013473. doi: 10.1016/j.bbrc.2020.08.086.", "ArticleIdList": ["10.1016/j.bbrc.2020.08.086", "PMC7447262", "32977949"]}, {"Citation": "Cheenpracha S, Karalai C, Ponglimanont C, Subhadhirasakul S, Tewtrakul S. Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorg Med Chem. 2006;14(6):1710\u20131714. doi: 10.1016/j.bmc.2005.10.019.", "ArticleIdList": ["10.1016/j.bmc.2005.10.019", "16263298"]}, {"Citation": "Kiat TS, Pippen R, Yusof R, Ibrahim H, Khalid N, Rahman NA. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett. 2006;16(12):3337\u20133340. doi: 10.1016/j.bmcl.2005.12.075.", "ArticleIdList": ["10.1016/j.bmcl.2005.12.075", "16621533"]}, {"Citation": "Liu H, Ye F, Sun Q, Liang H, Li C, Lu R, Huang B, Tan W, Lai L. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J Enzyme Inhib Med Chem. 2020;36(1):497\u2013503. doi: 10.1101/2020.04.10.035824.", "ArticleIdList": ["10.1101/2020.04.10.035824", "PMC7850424", "33491508"]}, {"Citation": "Su H, Yao S, Zhao W, Li M, Liu J, Shang W, Xie H, Ke C, Gao M, Yu K. Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro. BioRxiv. 2020 doi: 10.1101/2020.04.13.038687.", "ArticleIdList": ["10.1101/2020.04.13.038687", "0"]}, {"Citation": "Su H-x, Yao S, Zhao W-f, Li M-j, Liu J, Shang W-j, Xie H, Ke C-q, Hu H-c, Gao M-n, Yu K-q, Liu H, Shen J-s, Tang W, Zhang L-k, Xiao G-f, Ni L, Wang D-w, Zuo J-p, Jiang H-l, Bai F, Wu Y, Ye Y, Xu Y-c. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020;41(9):1167\u20131177. doi: 10.1038/s41401-020-0483-6.", "ArticleIdList": ["10.1038/s41401-020-0483-6", "PMC7393338", "32737471"]}, {"Citation": "Zandi K, Musall K, Oo A, Cao D, Liang B, Hassandarvish P, Lan S, Slack RL, Kirby KA, Bassit L, Amblard F, Kim B, AbuBakar S, Sarafianos SG, Schinazi RF. Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms. 2021;9(5):893. doi: 10.3390/microorganisms9050893.", "ArticleIdList": ["10.3390/microorganisms9050893", "PMC8143456", "33921971"]}, {"Citation": "Jeon S, Ko M, Lee J, Choi I, Byun Soo Y, Park S, Shum D, Kim S. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother. 2020;64(7):e00819\u201300820. doi: 10.1128/AAC.00819-20.", "ArticleIdList": ["10.1128/AAC.00819-20", "PMC7318052", "32366720"]}, {"Citation": "Cho J, Lee YJ, Kim JH, Kim Si, Kim SS, Choi B-S, Choi J-H. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Reports. 2020;10(1):16200. doi: 10.1038/s41598-020-72879-7.", "ArticleIdList": ["10.1038/s41598-020-72879-7", "PMC7530981", "33004837"]}, {"Citation": "Pollard BS, Blanco JC, Pollard JR. Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy. In Vivo. 2020;34(6):3723\u20133730. doi: 10.21873/invivo.12221.", "ArticleIdList": ["10.21873/invivo.12221", "PMC7811644", "33144490"]}, {"Citation": "Caohuy H, Eidelman O, Chen T, Yang Q, Bera A, Walton N, Pollard HB. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration into human lung cells. BioRxiv. 2021 doi: 10.1101/2021.06.02.446343.", "ArticleIdList": ["10.1101/2021.06.02.446343", "PMC8589851", "34773067"]}, {"Citation": "Nguyen PH, Tran VD, Pham DT, Dao TNP, Dewey RS. Use of and attitudes towards herbal medicine during the COVID-19 pandemic: a cross-sectional study in Vietnam. Euro J Integr Med. 2021;44:101328. doi: 10.1016/j.eujim.2021.101328.", "ArticleIdList": ["10.1016/j.eujim.2021.101328", "PMC9760728", "36570027"]}, {"Citation": "Luo H, Tang Q-L, Shang Y-X, Liang S-B, Yang M, Robinson N, Liu J-P. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26(4):243\u2013250. doi: 10.1007/s11655-020-3192-6.", "ArticleIdList": ["10.1007/s11655-020-3192-6", "PMC7088641", "32065348"]}, {"Citation": "Azam MNK, Al Mahamud R, Hasan A, Jahan R, Rahmatullah M. Some home remedies used for treatment of COVID-19 in Bangladesh. J Med Plant Stud. 2020;8(4):27\u201332."}, {"Citation": "MOA. Guidelines for Ayuverda Practitioners for COVID19. https://www.ayush.gov.in/docs/ayurved-guidlines.pdf. Accessed 28 May 2021"}, {"Citation": "Panyod S, Ho C-T, Sheen L-Y. Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective. J Tradit Complement Med. 2020;10(4):420\u2013427. doi: 10.1016/j.jtcme.2020.05.004.", "ArticleIdList": ["10.1016/j.jtcme.2020.05.004", "PMC7260602", "32691006"]}, {"Citation": "Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S, Chufang L, Jin Z, Zhenhua J, Haiming J. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharmacol Res. 2020;156:104761. doi: 10.1016/j.phrs.2020.104761.", "ArticleIdList": ["10.1016/j.phrs.2020.104761", "PMC7102548", "32205232"]}, {"Citation": "Deng W, Xu Y, Kong Q, Xue J, Yu P, Liu J, Lv Q, Li F, Wei Q, Bao L. Therapeutic efficacy of pudilan xiaoyan oral liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020;5(1):66. doi: 10.1038/s41392-020-0176-0.", "ArticleIdList": ["10.1038/s41392-020-0176-0", "PMC7205908", "32385228"]}, {"Citation": "Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19) Complement Ther Clin Pract. 2020;40:101214. doi: 10.1016/j.ctcp.2020.101214.", "ArticleIdList": ["10.1016/j.ctcp.2020.101214", "PMC7831809", "32891290"]}, {"Citation": "Sen B. Potentiality and possibility of medicinal plants on ayurvedic principle in prevention and treatment of COVID-19. J Ayurvedic Herb Med. 2020;6(2):100\u2013107. doi: 10.31254/jahm.2020.6216.", "ArticleIdList": ["10.31254/jahm.2020.6216"]}, {"Citation": "Anam E, Swachho RB, Jannat K, Rahmatullah M. Home remedies for COVID-19 treatment in Gazipur district, Bangladesh. J Med Plant. 2021;9(1):25\u201328."}, {"Citation": "Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytother Res. 2020;34(12):3411\u20133419. doi: 10.1002/ptr.6802.", "ArticleIdList": ["10.1002/ptr.6802", "PMC7436756", "32748969"]}, {"Citation": "Nawrot-Hadzik I, Zmudzinski M, Matkowski A, Preissner R, K\u0119sik-Brodacka M, Hadzik J, Drag M, Abel R. Reynoutria rhizomes as a natural source of SARS-CoV-2 Mpro inhibitors-molecular docking and in vitro study. Pharmaceuticals. 2021;14(8):742. doi: 10.3390/ph14080742.", "ArticleIdList": ["10.3390/ph14080742", "PMC8399519", "34451839"]}, {"Citation": "Li S-y, Chen C, Zhang H-q, Guo H-y, Wang H, Wang L, Zhang X, Hua S-n, Yu J, Xiao P-g, Li R-s, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res. 2005;67(1):18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, Zhang H, Yan Y, Zhao L, Li W, Zhang T, Xiao D, Guo X, Li Y, Yang J, Hu Z, Wang M, Zhong W. Anti-SARS-CoV-2 potential of artemisinins in vitro. ACS Infect Dis. 2020;6(9):2524\u20132531. doi: 10.1021/acsinfecdis.0c00522.", "ArticleIdList": ["10.1021/acsinfecdis.0c00522", "32786284"]}, {"Citation": "Raj V, Park JG, Cho K-H, Choi P, Kim T, Ham J, Lee J. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Int J Biol Macromol. 2021;168:474\u2013485. doi: 10.1016/j.ijbiomac.2020.12.020.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.12.020", "PMC7836687", "33290767"]}, {"Citation": "Ma Q, Li R, Pan W, Huang W, Liu B, Xie Y, Wang Z, Li C, Jiang H, Huang J, Shi Y, Dai J, Zheng K, Li X, Hui M, Fu L, Yang Z. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-\u03baB) signaling pathway. Phytomedicine. 2020;78:153296. doi: 10.1016/j.phymed.2020.153296.", "ArticleIdList": ["10.1016/j.phymed.2020.153296", "PMC7395229", "32890913"]}, {"Citation": "M\u00f6sbauer K, Fritsch VN, Adrian L, Bernhardt J, Gruhlke MCH, Slusarenko AJ, Niemeyer D, Antelmann H (2021) Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the Calu-3 proteome. bioRxiv. 10.1101/2021.05.15.444275"}, {"Citation": "Alhadrami HA, Sayed AM, Sharif AM, Azhar EI, Rateb ME. Olive-derived triterpenes suppress SARS COV-2 main protease: a promising scaffold for future therapeutics. Molecules. 2021;26(9):2654. doi: 10.3390/molecules26092654.", "ArticleIdList": ["10.3390/molecules26092654", "PMC8125615", "34062737"]}, {"Citation": "Alhadrami HA, Sayed AM, Hassan HM, Youssif KA, Gaber Y, Moatasim Y, Kutkat O, Mostafa A, Ali MA, Rateb ME, Abdelmohsen UR, Gamaleldin NM. Cnicin as an anti-SARS-CoV-2: an integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics. Antibiotics. 2021;10(5):542. doi: 10.3390/antibiotics10050542.", "ArticleIdList": ["10.3390/antibiotics10050542", "PMC8150330", "34066998"]}, {"Citation": "Gangadevi S, Badavath VN, Thakur A, Yin N, De Jonghe S, Acevedo O, Jochmans D, Leyssen P, Wang K, Neyts J, Yujie T, Blum G. Kobophenol A inhibits binding of host ACE2 receptor with spike RBD domain of SARS-CoV-2, a lead compound for blocking COVID-19. J Phys Chem Lett. 2021;12(7):1793\u20131802. doi: 10.1021/acs.jpclett.0c03119.", "ArticleIdList": ["10.1021/acs.jpclett.0c03119", "33577324"]}, {"Citation": "Xiong Y, Zhu G-H, Zhang Y-N, Hu Q, Wang H-N, Yu H-N, Qin X-Y, Guan X-Q, Xiang Y-W, Tang H, Ge G-B. Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: inhibition potentials, covalent binding sites and inhibitory mechanisms. Int J Biol Macromol. 2021;187:976\u2013987. doi: 10.1016/j.ijbiomac.2021.07.167.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.07.167", "PMC8322037", "34333006"]}, {"Citation": "Yang M, Wei J, Huang T, Lei L, Shen C, Lai J, Yang M, Liu L, Yang Y, Liu G. Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells. Phytother Res. 2020;2020:1\u20133. doi: 10.1002/ptr.6916.", "ArticleIdList": ["10.1002/ptr.6916", "PMC7753598", "33222316"]}, {"Citation": "Tietjen I, Cassel J, Register ET, Zhou XY, Messick TE, Keeney F, Lu LD, Beattie KD, Rali T, Ertl HCJ, Salvino JM, Davis RA, Montaner LJ (2021) The natural stilbenoid (\u2013)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants. bioRxiv. 10.1101/2021.04.29.442010", "ArticleIdList": ["PMC8597786", "34543092"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "23"}, {"Year": "2021", "Month": "9", "Day": "29"}, {"Year": "2021", "Month": "10", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "8", "Hour": "12", "Minute": "27"}, {"Year": "2021", "Month": "10", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34623617", "PMC8498083", "10.1007/s11418-021-01575-1", "10.1007/s11418-021-01575-1"]}}], "PubmedBookArticle": []}